IL6 and neoplasm: And indeed, not only IL-6-deficient [62] mice but also mice with hepatocyte-specific gp130-deficiency [91] display strongly impaired tumour formation not only in a murine DNA damage-driven HCC model but also in an obesity-driven liver tumour model.